Market Report / Biomed and tech lead TASE higher
Despite a drop in energy shares on reports of technical problems at the Tamar gas field, the Tel Aviv Stock Exchange edged up with help from Prolor Biotech and others.
The Tel Aviv Stock Exchange rose on Wednesday, led by technology and biomed shares after OPKO Health agreed to buy Israel-based biopharmaceutical company Prolor Biotech for stock worth about $480 million.
register with haaretz
Like us on Facebook and get articles directly in your news feed